Remote Customer Service Representative

We are seeking a friendly, professional, and customer-focused Remote Customer Service Representative to join our team. The successful candidate will serve as a point of contact for customers, helping address inquiries, resolve concerns, and provide a positive customer experience.

This position is ideal for someone with excellent communication skills, a problem-solving mindset, and the ability to work independently in a remote environment.

Key Responsibilities

• Respond to customer inquiries through email, phone, and other communication channels.
• Provide accurate information about company products, services, and policies.
• Listen carefully to customer concerns and provide appropriate solutions.
• Resolve customer complaints professionally and efficiently.
• Maintain accurate customer records and update information in the company's CRM system.
• Follow up with customers to ensure their concerns have been addressed.
• Collaborate with team members to improve customer satisfaction.
• Maintain a professional and positive approach in all customer interactions.

Required Qualifications

• High school diploma or equivalent.
• Excellent verbal and written communication skills.
• Strong active listening and problem-solving abilities.
• Good organizational and time-management skills.
• Basic computer skills and familiarity with CRM software.
• Ability to multitask and handle customer inquiries professionally.
• Previous customer service experience is an advantage but not required.

OMass Therapeutics integrates native mass spectrometry, specialized biochemistry, and custom chemistry to analyze drug targets in their native environments, studying intact protein assemblies outside the cell to achieve cell-system fidelity with cell-free precision.

The company is renowned for its proprietary OdyssION™ technology platform, which utilizes high-resolution native mass spectrometry to observe protein behavior and interactions. OMass Therapeutics advances both its internal pipeline—targeting areas such as congenital adrenal hyperplasia (CAH) and lupus—and strategic partnerships with major pharmaceutical companies.